Effects of functionalized silver nanoparticles on aggregation of human blood platelets.
Justyna HajtuchNadhim HanteEwelina TomczykMichal WojcikMarek Witold RadomskiMaria Jose Santos-MartinezIwona Inkielewicz-StepniakPublished in: International journal of nanomedicine (2019)
All tested functionalized AgNPs inhibited platelet aggregation at nontoxic concentrations. Therefore, functionalized AgNPs can be used as an antiplatelet agent or in design and manufacturing of blood-facing medical devices, such as vascular grafts, stents, heart valves, and catheters.